propranolol has been researched along with Leucocythaemia in 7 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Furthermore, in human leukemia U937 cells, it induced a marked and time-dependent reduction in the acetylation of lysine H4K5 and H3K9, a marked arrest in the G0/G1 phase and a significant increase in the hypodiploid nuclei percentage." | 3.81 | A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach. ( Balzano, AL; Castellano, S; Feoli, A; La Pietra, V; Mai, A; Marinelli, L; Milite, C; Novellino, E; Sasaki, K; Sbardella, G; Tosco, A, 2015) |
| "Treatment with propranolol slightly enhanced the proliferation of the RC-2A cells but did not markedly alter the growth rate of two other cell lines, regardless of their beta-adrenoceptor status." | 1.28 | Expression and function of beta-adrenergic receptors in human hematopoietic cell lines. ( Andersson, LC; Kontula, KK; Mäki, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Milite, C | 1 |
| Feoli, A | 1 |
| Sasaki, K | 1 |
| La Pietra, V | 1 |
| Balzano, AL | 1 |
| Marinelli, L | 1 |
| Mai, A | 1 |
| Novellino, E | 1 |
| Castellano, S | 1 |
| Tosco, A | 1 |
| Sbardella, G | 1 |
| Yuan, Y | 1 |
| Du, L | 1 |
| Tan, R | 1 |
| Yu, Y | 1 |
| Jiang, J | 1 |
| Yao, A | 1 |
| Luo, J | 1 |
| Tang, R | 1 |
| Xiao, Y | 1 |
| Sun, H | 1 |
| Hajighasemi, F | 1 |
| Hajighasemi, S | 1 |
| Domer, FR | 1 |
| Wigler, PW | 1 |
| Patterson, FK | 1 |
| Mäki, T | 1 |
| Andersson, LC | 1 |
| Kontula, KK | 1 |
| Cotias, CT | 1 |
| de Santana, CF | 1 |
| Pinto, Kde V | 1 |
7 other studies available for propranolol and Leucocythaemia
| Article | Year |
|---|---|
A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approach.
Topics: Acetylation; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Enzyme | 2015 |
Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.
Topics: Histone-Lysine N-Methyltransferase; Humans; Leukemia; Methyltransferases; Myeloid-Lymphoid Leukemia | 2022 |
Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro.
Topics: Adrenergic beta-Antagonists; Carcinogens; Enzyme Activation; Humans; Jurkat Cells; Leukemia; Matrix | 2009 |
Priapism in children with leukemia.
Topics: Humans; Leukemia; Male; Priapism; Propranolol | 1982 |
Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; | 1994 |
Expression and function of beta-adrenergic receptors in human hematopoietic cell lines.
Topics: Blood Cells; Blotting, Southern; Cell Division; Cell Line; Cyclic AMP; DNA; DNA, Neoplasm; Humans; I | 1992 |
[Prevention of arrhythmia caused by chronic retamycin (complex) poisoning by using adrenergic blokaders].
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Arrhythmias, Cardiac; Body Weight; Chron | 1971 |